Sorrento Therapeutics CEO details Covishield neutralizing antibody

175,848 次觀看・3 年前

Sorrento Therapeutics Chairman and CEO Henry Ji joins Yahoo Finance Live to discuss the Covishield antibody Sorrento is developing, the timeline for getting FDA approval, cancer treatment research, and the pharmaceutical biotech sectors.